$35.15 B
Share price
Change (1 day)
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Market capitalization of Biogen (BIIB)

Market cap: $35.15 Billion

As of January 2022 Biogen has a market cap of $35.15 Billion. This makes Biogen the world's 574th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Biogen from 2004 to 2022

Year Market cap Change
2022$35.15 B1.65%
2021$34.58 B-8.23%
2020$37.67 B-27.11%
2019$51.69 B-12.89%
2018$59.34 B-11.92%
2017$67.37 B9.19%
2016$61.69 B-7.87%
2015$66.96 B-15.89%
2014$79.62 B20.51%
2013$66.07 B90.8%
2012$34.62 B29.53%
2011$26.73 B65.75%
2010$16.12 B9.68%
2009$14.70 B7.18%
2008$13.71 B-18.49%
2007$16.83 B1.49%
2006$16.58 B7.9%
2005$15.36 B-32.09%
2004$22.63 B

End of Day market cap according to different sources

On Jan 15th, 2022 the market cap of Biogen was reported to be:

$35.15 Billion
by Yahoo Finance
$35.15 Billion
by CompaniesMarketCap
$35.15 Billion
by Nasdaq
$34.76 Billion
by Reuters
$35.15 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$441.85 B 1,157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$308.42 B 777.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$240.20 B 583.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$132.57 B 277.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$130.71 B 271.86%๐Ÿ‡ซ๐Ÿ‡ท France
$90.02 B 156.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.32 B 80.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.02 B-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.02 B-68.65%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$18.94 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA